Evaxion biotech to host q1 2021 corporate update conference call & webcast on may 13

Copenhagen, denmark, may 06, 2021 (globe newswire) -- evaxion biotech a/s (nasdaq: evax), a clinical-stage biotechnology company specializing in the development of ai-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today that it will present its first-quarter 2021 financial results on may 13.
EVAX Ratings Summary
EVAX Quant Ranking